Imunon Intangible Assets from 2010 to 2026
| IMNN Stock | USD 3.18 0.14 4.22% |
Intangible Assets | First Reported 1996-09-30 | Previous Quarter 13.4 M | Current Value 13.4 M | Quarterly Volatility 9.8 M |
Check Imunon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Imunon's main balance sheet or income statement drivers, such as Depreciation And Amortization of 867.1 K, Interest Expense of 0.0 or Selling General Administrative of 6.3 M, as well as many indicators such as Price To Sales Ratio of 24.23, Dividend Yield of 0.0 or PTB Ratio of 2.8. Imunon financial statements analysis is a perfect complement when working with Imunon Valuation or Volatility modules.
Imunon | Intangible Assets | Build AI portfolio with Imunon Stock |
Evaluating Imunon's Intangible Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Imunon Inc's fundamental strength.
Latest Imunon's Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of Imunon Inc over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Imunon's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Imunon's overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
Imunon Intangible Assets Regression Statistics
| Arithmetic Mean | 14,898,885 | |
| Geometric Mean | 6,255,379 | |
| Coefficient Of Variation | 56.90 | |
| Mean Deviation | 6,122,339 | |
| Median | 15,371,169 | |
| Standard Deviation | 8,476,946 | |
| Sample Variance | 71.9T | |
| Range | 25.8M | |
| R-Value | 0.21 | |
| Mean Square Error | 73.4T | |
| R-Squared | 0.04 | |
| Significance | 0.43 | |
| Slope | 344,472 | |
| Total Sum of Squares | 1149.7T |
Imunon Intangible Assets History
About Imunon Financial Statements
Imunon investors utilize fundamental indicators, such as Intangible Assets, to predict how Imunon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 15.4 M | 16.1 M |
Pair Trading with Imunon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Imunon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Imunon will appreciate offsetting losses from the drop in the long position's value.Moving together with Imunon Stock
Moving against Imunon Stock
| 0.65 | VYNE | Vyne Therapeutics | PairCorr |
| 0.61 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
| 0.59 | KOD | Kodiak Sciences | PairCorr |
| 0.55 | VRTX | Vertex Pharmaceuticals Earnings Call Tomorrow | PairCorr |
| 0.47 | FBIO | Fortress Biotech | PairCorr |
The ability to find closely correlated positions to Imunon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Imunon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Imunon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Imunon Inc to buy it.
The correlation of Imunon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Imunon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Imunon Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Imunon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Imunon Correlation against competitors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Will Biotechnology sector continue expanding? Could Imunon diversify its offerings? Factors like these will boost the valuation of Imunon. Market participants price Imunon higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Imunon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Imunon Inc requires distinguishing between market price and book value, where the latter reflects Imunon's accounting equity. The concept of intrinsic value—what Imunon's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Imunon's price substantially above or below its fundamental value.
Please note, there is a significant difference between Imunon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Imunon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Imunon's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.